Literature DB >> 16970147

Hyponatremia: why it matters, how it presents, how we can manage it.

Ivor Douglas1.   

Abstract

Hyponatremia is a common electrolyte disorder among hospitalized patients and has been associated with increased mortality. Most patients are asymptomatic, but many do present with symptoms, usually of a generalized neurologic nature. Based-on medical history, physical examination (including volume-status assessment), and laboratory tests, patients can be classified as having either hypervolemic, euvolemic, or hypovolemic hyponatremia. Management depends on the speed of hyponatremia onset; its degree, duration, and symptoms; and whether there are risk factors for neurologic complications. The risks of overly rapid correction must be weighed against the benefits of treating hyponatremia. Traditional therapies have significant limitations. New agents that antagonize arginine vasopressin at the V2 receptor or both the V(1A) and V2 receptors show promise for treating hypervolemic and euvolemic hyponatremia, as they induce desired free water diuresis without inducing sodium excretion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970147     DOI: 10.3949/ccjm.73.suppl_3.s4

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  9 in total

1.  Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.

Authors:  William T Abraham; Juan M Aranda; John P Boehmer; Uri Elkayam; Edward M Gilbert; Stephen S Gottlieb; Gerd Hasenfuss; Marrick Kukin; Brian D Lowes; John B O'Connell; Luigi Tavazzi; Arthur M Feldman; Barry Ticho; Cesare Orlandi
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

Review 2.  Diagnosis and management of hyponatremia in cancer patients.

Authors:  Jorge J Castillo; Marc Vincent; Eric Justice
Journal:  Oncologist       Date:  2012-05-22

3.  Hyponatremia and Cognitive Impairment in Patients Treated with Peritoneal Dialysis.

Authors:  Rong Xu; Hai-chen Pi; Zu-ying Xiong; Jin-lan Liao; Li Hao; Gui-ling Liu; Ye-Ping Ren; Qin Wang; Zhao-xia Zheng; Li-ping Duan; Jie Dong
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

Review 4.  Psychogenic polydipsia review: etiology, differential, and treatment.

Authors:  Brian Dundas; Melissa Harris; Meera Narasimhan
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

Review 5.  Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.

Authors:  Paul Gaglio; Kwaku Marfo; Joseph Chiodo
Journal:  Dig Dis Sci       Date:  2012-06-26       Impact factor: 3.199

6.  Rapid correction of severe hyponatremia after hysteroscopic surgery – a case report.

Authors:  Philip Hepp; Tobias Jüttner; Ines Beyer; Tanja Fehm; Wolfgang Janni; Enrico Monaca
Journal:  BMC Anesthesiol       Date:  2015-06-09       Impact factor: 2.217

7.  Recurrent episodic vertigo secondary to hyponatremic encephalopathy from water intoxication.

Authors:  Jiann-Jy Chen; Hsin-Feng Chang; Dem-Lion Chen
Journal:  Neurosciences (Riyadh)       Date:  2014-10       Impact factor: 0.735

8.  Therapeutic Approach to the Management of Severe Asymptomatic Hyponatremia.

Authors:  Thaofiq Ijaiya; Sandhya Manohar; Kameswari Lakshmi
Journal:  Case Rep Nephrol       Date:  2017-07-27

9.  Hyponatremia Presenting with Recurrent Mania.

Authors:  Sahil Parag; Eduardo D Espiridion
Journal:  Cureus       Date:  2018-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.